News

"Longer follow-ups after the pandemic are needed to investigate persistent brain aging effects and their long-term ...
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
LAVAL, QC / ACCESS Newswire / July 24, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified ...
The Swiss drugmaker discussed the option of selling drugs directly to patients with U.S. officials following Trump ...
On CNBC's "Mad Money Lightning Round," Jim Cramer praised home improvement retailer Lowe's Companies and CrowdStrike Holdings ...
However, yesterday GSK announced that the FDA has extended the review period for Blenrep to give the agency time to review ...
In this exclusive Drug Digest video, Deepak Bahl from Roquette and Jagruti Patel from Lonza look at strategies for ...
The Subject Expert Committee (SEC) under the Cardiovascular division of the Central Drugs Standard Control Organisation (CDSCO) has approved the protocol amendment submitted ...
Rocket Pharmaceuticals will cut 80 jobs and streamline operations, focusing on gene therapies to drive long-term growth.
Dispatch, based in Philadelphia and San Francisco, is developing a platform to carr novel antigens to solid tumors.
Zydus Lifesciences has appealed a Delhi High Court order that restricts the company from producing and selling its biosimilar cancer drug, ZRC-3276.